评价复方甘草酸苷与氯雷他啶联合应用对亚急性湿疹的疗效及安全性  

Evaluate the Efficacy and Safety of Compound Glycyrrhizin Combined with Loratadine in Treating Subacute Eczema

作　　者：翟灵仙 ZHAI Ling-xian(The First People's Hospital of Xining,Xining,Qinghai 810000)

机构地区：[1]青海省西宁市第一人民医院

出　　处：《智慧健康》2019年第31期121-122,共2页Smart Healthcare

摘　　要：目的分析复方甘草酸苷与氯雷他啶联合应用对亚急性湿疹的效果。方法将2017年11月至2019年4月来我院就诊的80例亚急性湿疹患者作为本次研究对象,根据入院先后顺序将其分为对照组和治疗组,各40例。其中对照组仅给予氯雷他啶治疗,治疗组给予复方甘草酸苷结合氯雷他啶治疗。研究结束后,对两组患者的治疗效果以及并发症发生率进行对比。结果治疗组的治疗效果高于对照组,对比具有统计学意义(P<0.05)。治疗组的并发症发生率低于对照组,但差异较小,不具有统计学意义(P>0.05)。结论对亚急性湿疹患者采用复方甘草酸苷结合氯雷他啶进行治疗可有效地提高患者临床治愈率,降低并发症的发生率,值得推广。Objective To analyze the effect of compound glycyrrhizin combined with loratadine on subacute eczema. Methods Eighty patients with subacute eczema who came to our hospital from November 2017 to April 2019 were divided into control group(n =40) and treatment group(n =40) according to the order of admission. The control group was treated with loratadine only, and the treatment group was treated with compound glycyrrhizin combined with loratadine. At the end of the study, the therapeutic effect and the incidence of complications in the two groups were studied. Results The therapeutic effect of the treatment group was higher than that of the control group, and the comparison was statistically significant(P< 0.05). The incidence of complications in the treatment group was lower than that in the control group, but the difference was not statistically significant(P> 0.05). Conclusion Compound glycyrrhizin combined with loratadine in the treatment of subacute eczema can effectively improve the clinical cure rate and reduce the incidence of complications, which is worthy of promotion.

关 键 词：复方甘草酸苷 氯雷他啶 亚急性湿疹 疗效 

分 类 号：R28[医药卫生—中药学]